0001209191-18-056049.txt : 20181024
0001209191-18-056049.hdr.sgml : 20181024
20181024161844
ACCESSION NUMBER: 0001209191-18-056049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181022
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mow Jonathan P
CENTRAL INDEX KEY: 0001313942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 181136609
MAIL ADDRESS:
STREET 1: 2025 1ST AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-22
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001313942
Mow Jonathan P
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
1
1
0
0
Chief Executive Officer
Common Stock
2018-10-22
4
C
0
310
A
310
D
Common Stock
2018-10-22
4
C
0
3505
A
48699
I
By the Mow Trust dated April 17, 2008
Warrants to Purchase Series B Preferred Stock
0.12
2018-10-22
4
M
0
310
0.00
D
Series B Preferred Stock
310
0
D
Series B Preferred Stock
2018-10-22
4
M
0
310
0.12
A
Common Stock
310
310
D
Series B Preferred Stock
2018-10-22
4
C
0
310
0.00
D
Common Stock
310
0
D
Series B Preferred Stock
2018-10-22
4
C
0
3505
0.00
D
Common Stock
3505
0
I
By the Mow Trust dated April 17, 2008
Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.
The reporting person and his wife are joint trustees of the Mow Trust dated April 17, 2008 and share voting and dispositive power for such shares. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Represents the exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.
The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.
/s/ Darren K. DeStefano, Attorney-in-Fact
2018-10-24